
FDA Grants Breakthrough Status to CAR-T Therapy for Pediatric Brain Tumor
The United States Food and Drug Administration (FDA) has granted breakthrough therapy designation to treatment with an investigational B7-H3 targeting autologous CAR-T cell therapy for pediatric patients with diffuse intrinsic pontine glioma, an incurable …